Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory MeningiomaTerminated
NCT03267836Phase 1Updated Jun 15, 2023
Sponsor: Washington University School of Medicine
Meningioma · Meningioma, Adult
United States
Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBDTerminated
NCT02255227Phase 2Updated Jun 15, 2023
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Infections, Pneumococcal · Bowel Diseases, Inflammatory
France
A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis SuppurativaCompleted
NCT04092452Phase 2Updated Jun 15, 2023
Sponsor: Pfizer
Acne Inversa
United States, Australia, Canada
20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy InfantsCompleted
NCT04379713Phase 3Updated Jun 13, 2023
Sponsor: Pfizer
Pneumococcal Disease
United States, Argentina, Canada, Chile, Czechia +6 more
Apixaban Drug Utilization Study In Stroke Prevention In Atrial Fibrillation (Spaf)Completed
NCT03441633N/AUpdated Jun 9, 2023
Sponsor: Pfizer
Atrial Fibrillation
Spain
Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTXCompleted
NCT03975790N/AUpdated Jun 9, 2023
Sponsor: Pfizer
Rheumatoid Arthritis
United States
A Study to Evaluate Patient Characteristics and Treatment Patterns Among Rheumatoid Arthritis PatientsCompleted
NCT04047121N/AUpdated Jun 9, 2023
Sponsor: Pfizer
Rheumatoid Arthritis
United States
Dasatinib and Crizotinib in Advanced CancerCompleted
NCT01744652Phase 1Updated Jun 7, 2023
Sponsor: M.D. Anderson Cancer Center
Advanced Cancers
United States
Acute Myeloid Leukemia Real World Treatment PatternsWithdrawn
NCT04230564N/AUpdated Jun 7, 2023
Sponsor: Pfizer
Leukemia, Myeloid, Acute
Long Term Use Of Xalacom In Patients Glaucoma Or Ocular HypertensionCompleted
NCT01191008N/AUpdated Jun 1, 2023
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Glaucoma · Ocular Hypertension
An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain MetastasisTerminated
NCT03911869Phase 2Updated May 31, 2023
Sponsor: Pfizer
Brain Metastases
United States, Argentina, Australia, Belgium, Italy
Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant GliomasCompleted
NCT02238496Phase 1Updated May 25, 2023
Sponsor: Andrew B Lassman, MD
Brain Tumor, Recurrent · Glioblastoma · Anaplastic Astrocytoma · Anaplastic Oligodendroglioma
United States
Efficacy of Treatment Sequences in Patients With Non-small Cell Lung Cancer Receiving LorlatinibCompleted
NCT03727477N/AUpdated May 24, 2023
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Non-small Cell Lung Cancer Metastatic · ALK Gene Rearrangement Positive · ROS-1 Gene Rearrangement Positive
France
Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal CancerCompleted
NCT00593060Phase 1Updated May 24, 2023
Sponsor: Jeffrey W. Clark, MD
Colorectal Cancer · Colorectal Adenocarcinoma
United States
Impact of Prevnar 13 on Ear Infections in ChildrenCompleted
NCT01272999N/AUpdated May 23, 2023
Sponsor: Pfizer
Acute Otitis Media · Mastoiditis
United States
Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast CancerCompleted
NCT00656669NAUpdated May 23, 2023
Sponsor: Indiana University
Breast Cancer
United States
Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With MedicareCompleted
NCT04681482N/AUpdated May 22, 2023
Sponsor: Pfizer
Atrial Fibrillation · Obesity · Anticoagulants
United States
Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE)Completed
NCT02958527N/AUpdated May 22, 2023
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Depression/Depressed State
A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A DayCompleted
NCT04267380N/AUpdated May 22, 2023
Sponsor: Pfizer
Arthritis Rheumatoid
United States
Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of MigraineCompleted
NCT04408794Phase 2, Phase 3Updated May 18, 2023
Sponsor: Pfizer
Acute Migraine
United States
Assessment of the Effectiveness and Safety Outcome in Patients With Atrial Fibrillation Treated by Apixaban in BelgiumWithdrawn
NCT05116267N/AUpdated May 17, 2023
Sponsor: Pfizer
Atrial Fibrillation
Belgium
Quantification of the Socio-economic Multifacet Burden of Alopecia Areata and Identification of the Associated FactorsUnknown
NCT05588310N/AUpdated May 15, 2023
Sponsor: University Hospital, Toulouse
Alopecia Areata
France
Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSVWithdrawn
NCT04267822Phase 2Updated May 8, 2023
Sponsor: Pfizer
RSV Infection · Stem Cell Transplant Complications · Lower Resp Tract Infection
Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC PatientsRecruiting
NCT05817903Phase 2Updated May 8, 2023
Sponsor: Consorzio Oncotech
Metastatic Renal Cell Carcinoma
Italy
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 InfectionCompleted
NCT05047601Phase 2, Phase 3Updated May 6, 2023
Sponsor: Pfizer
COVID-19
United States, Argentina, Brazil, Bulgaria, Colombia +12 more

Previous page Next page